Proactive Investors - Run By Investors For Investors

Precision Therapeutics’ stock soars after its Skyline Medical division expands footprint in New England

The company sold six STREAMWAY systems to Yale University’s ambulatory outpatient surgical center
A hospital
The Eagan, Minnesota, company manufactures environmentally safe systems for the collection and disposal of infectious fluids from surgical procedures and post-operative care

Shares of Precision Therapeutics Inc (NASDAQ:AIPT) soared Thursday after it announced that its Skyline Medical division significantly expanded its footprint in New England with the sale of six STREAMWAY systems to Yale University’s ambulatory outpatient surgical center.

Skyline's novel FDA-cleared STREAMWAY System suctions surgical waste fluid from the patient using standard surgical tubing and disposables. It connects directly to a hospital’s plumbing system to automate the collection and disposal of waste fluids.

Precision Therapeutics’ stock shot up 10.1% $0.98.

READ: Adamis Pharma's stock soars after commercial partner launches Epi pen alternative in the US

The Eagan, Minnesota, company provides healthcare products and services primarily in the United States. The company manufactures environmentally conscious systems for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care.

The company markets and sells its STREAMWAY Fluid Waste Management system to medical facilities through its sales force and independent distributors.

Contact Uttara Choudhury at [email protected]

Follow her on Twitter@UttaraProactive 

View full AIPT profile View Profile

Precision Therapeutics Inc Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use